the who updated diagnostic criteria for et, pv & mf
Published 7 years ago • 5.5K plays • Length 21:26Download video MP4
Download video MP3
Similar videos
-
25:48
the who updated diagnostic criteria for mpn
-
26:50
“masked” polycythemia vera: time to change who diagnostic criteria
-
3:41
what is the who essential diagnostics list for a better access to diagnostics?
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
21:02
mf marrow morphology: key takeaways from who 2016 diagnostic update
-
19:41
recent advances in the diagnosis, prognosis and survival predictions of patients with pv
-
21:11
mf marrow morphology: key takeaways from who 2016 diagnostic update
-
17:02
indication for cytoreductive therapy in et and pv: do we have it right?
-
29:27
my view on current and future use of jak inhibitors for et, pv, and mf
-
19:04
my view on current and future use of jak inhibitors for et, pv, and mf
-
19:03
assessment of novel treatment options for patients with pv
-
13:49
“masked” polycythemia vera and polycythemia vera “in evolution”
-
18:36
diagnostic challenges in mpn
-
18:50
jak inhibitors for et and pv: what have we learned so far?
-
18:09
diagnosis, prognosis, and therapy of true et vs. prefibrotic mf
-
27:39
interplay of somatic and germline variants in mpn
-
19:36
evolution of the assessment of clinical benefit in polycythemia vera
-
19:02
prognostication and initiation of therapy in polycythemia vera: do we have it right?